Second Variation Agreement to the Contract for the Provision of Goods and Services to Support the UK Covid-19 Testing Strategy

Concepts

• medical laboratories
• second variation agreement
• provision of goods
• uk covid-19 testing strategy
• end point pcr
• labour
• equipment

Location

London

Description

Labour and equipment to accommodate end point PCR — GBP 1 179 565 End point PCR running costs — GBP 31 050 000.

Ammendments to Previous Notice

Award Detail

CPV Codes

• 85145000 - Services provided by medical laboratories

Indicators

• Contract modified due to additional needs.

Legal Justification

The modifications were undertaken pursuant to Regulation 72(1)(b) of the Public Contract Regulations 2015. As part of the national testing programme, new high throughput ePCR technology was required in order to meet national demand for testing services. Previous proof of concept activity undertaken by UK Biocentre in its Milton Keynes lab means that it had LGC machines already installed and existing experience of operation of ePCR. Moving the ePCR services to a new facility for a period which is potentially less than a year would cause significant inconvenience and/or substantial duplication of costs for DHSC. The increase in price from the modification does not exceed 50 % of the value of the original contract.